β受体阻滞剂对室性心律失常的疗效评价  

Efficacy evaluation of β blockers on ventricular arrhythmias

作　　者：曹克将 

机构地区：[1]南京医科大学第一附属医院心内科,江苏省心肺疾病研究所,江苏南京210029

出　　处：《实用心电学杂志》2017年第3期153-156,共4页Journal of Practical Electrocardiology

摘　　要：室性心律失常在临床上十分常见,多见于结构性心脏病患者,也可发生于无心脏病者。虽然近年来非药物治疗技术不断涌现,但是抗心律失常药物仍然是基本和主要的治疗选择。在目前应用的四大类抗心律失常药物中,β受体阻滞剂是唯一可以降低总死亡率的抗心律失常药物。本文就β受体阻滞剂对不同类型室性心律失常的治疗效果进行评价。Ventricular arrhythmia is commonly seen in clinical practice. It is more common in patients with structural heart disease and can also occur in people without heart disease. Although more and more non-drug therapies have been emerging in recent years, antiarrhythmic drugs are still the basic and primary choice of treatment. Among the four major categories of antiarrhythmic drugs applied at present, ｜3 blockers is the only one which could reduce the total mortality rate. This paper evaluates its effectiveness on different kinds of ventricular arrhythmias.

关 键 词：室性心律失常 Β受体阻滞剂 抗心律失常治疗 

分 类 号：R540.4[医药卫生—心血管疾病]